Description
An FPP synthase inhibitor (IC50s = 0.85 and 0.20 µM in J774 cells and for human recombinant FPP synthase, respectively); inhibits bone resorption in rats when used at doses of 16 µmol/kg per day and impairs long bone growth at ≥40 µmol/kg per day; has anti-hypercalcemic effects in a rat hypercalcemia model; high concentrations induce activation of MMP-2, NF-κB, and caspase-3, leading to cell death
Formal name: P,P’-(3-amino-1-hydroxypropylidene)bis-phosphonic acid, disodium salt
Synonyms: APD|CGP 23339A|Pamidronic Acid
Molecular weight: 279
CAS: 57248-88-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Endocrinology & Metabolism|Bone Growth & Remodeling